The association of MUC16 mutation with tumor mutation burden and its prognostic implications in cutaneous melanoma

BACKGROUND: MUC16 is a mucin marker that is frequently mutated in melanoma; but whether MUC16 mutations could be useful as a surrogate biomarker for tumor mutation burden (TMB) remains unclear. METHODS: This study rigorously evaluates the MUC16 mutation as a clinical biomarker in cutaneous melanoma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Epidemiol Biomarkers Prev
Autors principals: Wang, Xuefeng, Yu, Xiaoqing, Krauthammer, Michael, Hugo, Willy, Duan, Chunzhe, Kanetsky, Peter A., Teer, Jamie K., Thompson, Zachary J., Kalos, Denise, Tsai, Kenneth Y., Smalley, Keiran S.M., Sondak, Vernon K., Chen, Y Ann, Conejo-Garcia, Jose R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483810/
https://ncbi.nlm.nih.gov/pubmed/32611582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-20-0307
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars